Published in TB and Outbreaks Week, December 27th, 2011
"Retrospective study of all hematology patients given MV with IPA between January 1998 and March 2011 at a single center. Predictors of 6-month survival or mortality were identified using multivariable analysis. We studied 67 patients including 49 (73%) with neutropenia, 23 (34%) with long-term steroid therapy, and 14...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week